chr14-45136202-G-C

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020937.4(FANCM):​c.171G>C​(p.Leu57Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00236 in 1,614,190 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0015 ( 1 hom., cov: 32)
Exomes š‘“: 0.0024 ( 8 hom. )

Consequence

FANCM
NM_020937.4 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 2.89
Variant links:
Genes affected
FANCM (HGNC:23168): (FA complementation group M) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010391653).
BP6
Variant 14-45136202-G-C is Benign according to our data. Variant chr14-45136202-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 313188.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Benign=1, Uncertain_significance=2}. Variant chr14-45136202-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00155 (236/152298) while in subpopulation NFE AF= 0.0027 (184/68030). AF 95% confidence interval is 0.00239. There are 1 homozygotes in gnomad4. There are 113 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCMNM_020937.4 linkc.171G>C p.Leu57Phe missense_variant Exon 1 of 23 ENST00000267430.10 NP_065988.1 Q8IYD8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCMENST00000267430.10 linkc.171G>C p.Leu57Phe missense_variant Exon 1 of 23 1 NM_020937.4 ENSP00000267430.5 Q8IYD8-1

Frequencies

GnomAD3 genomes
AF:
0.00155
AC:
236
AN:
152180
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00270
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00174
AC:
437
AN:
251472
Hom.:
1
AF XY:
0.00182
AC XY:
247
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000719
Gnomad FIN exome
AF:
0.000785
Gnomad NFE exome
AF:
0.00282
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00244
AC:
3573
AN:
1461892
Hom.:
8
Cov.:
32
AF XY:
0.00245
AC XY:
1782
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
Gnomad4 AMR exome
AF:
0.00101
Gnomad4 ASJ exome
AF:
0.00142
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000985
Gnomad4 FIN exome
AF:
0.000749
Gnomad4 NFE exome
AF:
0.00288
Gnomad4 OTH exome
AF:
0.00238
GnomAD4 genome
AF:
0.00155
AC:
236
AN:
152298
Hom.:
1
Cov.:
32
AF XY:
0.00152
AC XY:
113
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.000457
Gnomad4 AMR
AF:
0.000915
Gnomad4 ASJ
AF:
0.00317
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00270
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00229
Hom.:
0
Bravo
AF:
0.00167
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00161
AC:
195

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

FANCM: BS1 -

Jun 17, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 28881617, 29217778, 28717660, 30426508, 26517685) -

Nov 10, 2022
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:2
Jul 30, 2021
Sema4, Sema4
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Nov 28, 2024
Molecular Diagnostics Laboratory, Catalan Institute of Oncology
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

BS2, BP4_Moderate c.171G>C, located in exon 1 of the FANCM gene, is predicted to result in the substitution of leucine by phenylalanine at codon 57, p.(Leu57Phe). This variant is found in 452/268342 alleles at a frequency of 0.1% in the gnomAD v2.1.1 database, non-cancer dataset. This variant has been observed in homozygous state in multiple healthy individuals in the gnomAD v4 database (BS2). The SpliceAI algorithm predicts no significant impact on splicing. The REVEL meta-predictor score for this variant (0.064) suggests that it does not affect the protein function according to Pejaver 2022 thresholds (PMID: 36413997) (BP4_Moderate). To our knowledge, neither relevant clinical data nor well-established functional studies have been reported for this variant. It has been reported in oncologic and hemato-oncologic patients (PMID:38927643, 29217778,28717660, 26740942). This variant has been reported in the ClinVar database (2x benign, 6x likely benign, 1x uncertain significance) and in LOVD (1x likely benign, 2x uncertain significance). Based on currently available information, the variant c.171G>C should be considered a likely benign variant, according to ACMG/AMP classification guidelines. -

Spermatogenic failure 28;C4748170:Premature ovarian failure 15 Uncertain:1
-
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

FANCM NM_020937 exon 1 p.Leu57Phe (c.171G>C): This variant has not been reported in the literature but is present in 0.3% (354/126714) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs142007602). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

not specified Benign:1
May 03, 2021
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Fanconi anemia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

FANCM-related disorder Benign:1
Aug 02, 2024
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
.;T;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.84
T;T;T
M_CAP
Benign
0.0061
T
MetaRNN
Benign
0.010
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;M;M
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-2.5
N;N;N
REVEL
Benign
0.064
Sift
Benign
0.048
D;D;T
Sift4G
Benign
0.17
T;T;T
Polyphen
0.026
B;B;.
Vest4
0.15
MutPred
0.47
Gain of catalytic residue at Y62 (P = 0.0458);Gain of catalytic residue at Y62 (P = 0.0458);Gain of catalytic residue at Y62 (P = 0.0458);
MVP
0.45
MPC
0.11
ClinPred
0.062
T
GERP RS
1.1
Varity_R
0.12
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142007602; hg19: chr14-45605405; COSMIC: COSV104566925; COSMIC: COSV104566925; API